Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A New Jersey judge decides to allow to permit further litigation in a whistleblower lawsuit accusing Boston Scientific of defrauding Medicare and promoting off-label uses of its spinal cord stimulation system. A New Jersey judge decided last week to allow accusers to move forward with a lawsuit against medical device giant Boston Scientific (NYSE:BSX) and its neuromodulation unit. The lawsuit, filed in March 2011 and unsealed in August 2012, alleges that Boston Scientific ran a scheme to defraud Medicare and promote off-label use of its Precision Plus spinal cord stimulation system.
Help employers find you! Check out all the jobs and post your resume.
